INHIBITION OF RELEASE OF INTERLEUKIN-2 BY VINCRISTINE AND VINBLASTINE

被引:9
作者
AHMED, K
HAMIED, TAA
TURK, JL
机构
关键词
D O I
10.3109/08923978709035221
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:391 / 407
页数:17
相关论文
共 21 条
[1]   INVIVO OR INVITRO MODULATING EFFECTS OF VINCRISTINE ON THE GENERATION OF ALLOGENEIC CYTO-TOXIC LYMPHOCYTES INVITRO [J].
BARTOCCI, A ;
RICCARDI, C ;
BONMASSAR, E .
JOURNAL OF IMMUNOPHARMACOLOGY, 1980, 2 (01) :61-72
[2]  
BOLIVAR R, 1980, CANCER, V46, P1555, DOI 10.1002/1097-0142(19801001)46:7<1555::AID-CNCR2820460710>3.0.CO
[3]  
2-4
[4]  
BOREL JF, 1976, IMMUNOLOGY, V31, P631
[5]  
CREASEY WA, 1975, ANTINEOPLASTIC IMM 2, P670
[6]  
EDELMAN GM, 1973, P NATL ACAD SCI USA, V70, P1442, DOI 10.1073/pnas.70.5.1442
[7]   SELECTIVE EFFECTS OF ADRIAMYCIN ON MURINE HOST DEFENSE SYSTEMS [J].
EHRKE, MJ ;
COHEN, SA ;
MIHICH, E .
IMMUNOLOGICAL REVIEWS, 1982, 65 :55-78
[8]  
GILLIS S, 1978, J IMMUNOL, V120, P2027
[9]   ENHANCEMENT OF DELAYED-HYPERSENSITIVITY REACTION WITH VARIETIES OF ANTI-CANCER DRUGS - A COMMON BIOLOGICAL PHENOMENON [J].
GOTO, M ;
MITSUOKA, A ;
SUGIYAMA, M ;
KITANO, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 154 (01) :204-209
[10]   POTENTIATION OF RELEASE OF INTERLEUKIN-2 BY BLEOMYCIN [J].
HAMIED, TAA ;
PARKER, D ;
TURK, JL .
IMMUNOPHARMACOLOGY, 1986, 12 (02) :127-134